| Latest Forum Topics / Biosensors |
 Post Reply
|
|
Is Biosensors a good buy?
|
|||||
|
iPunter
Supreme |
06-Apr-2010 12:33
|
||||
|
x 0
x 0 Alert Admin |
My trading style is way different from Livermore's. I can't stand even a small loss, thus I cut loss very fast. The moment the subtle signs show that I am wrong in my anticipation, I promptly dump... There's always another good trade to be taken...
|
||||
| Useful To Me Not Useful To Me | |||||
|
iPunter
Supreme |
03-Apr-2010 11:29
|
||||
|
x 0
x 0 Alert Admin |
Thsoe who entered @ .705/.71 may wish to hold and let their profit run... While ordering their dinner @TungLok... hehehe... 
|
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
junction
Senior |
03-Apr-2010 11:11
|
||||
|
x 0
x 0 Alert Admin |
I Punter must have made money on Biosensor. He is obviously a shrewd investor although I cannot fathom his trading technique. I can better understand Livermore's strategy. I still need to learn from both of them.
|
||||
| Useful To Me Not Useful To Me | |||||
|
pharoah88
Supreme |
02-Apr-2010 21:23
|
||||
|
x 0
x 0 Alert Admin |
biO has nO sensOr ????
|
||||
| Useful To Me Not Useful To Me | |||||
|
investor
Senior |
02-Apr-2010 15:43
|
||||
|
x 0
x 0 Alert Admin |
Nomura has yet come out with another report on Biosensors. ( I admire their pro-active approach and enthusiam, and the courage of their conviction). Main points are : . They say that there is no fundamental basis for the steep drop in price. Their RECENT plant visit shows that operations are running smoothly with 24 hr shfts, 7 days a week. . Biosensors' distributor, Krauth continues to distribute the Bio-matrix in Germany, and will likely present clinical data in the German Cardiac meeting on 8th April. . Key events happening for Biosensors in Q1 2011 (ie Apr 2010 - Jun 2010), Namely, Terumo's Nobori Japan Clinical Trial update on 29th Apr 2010, during the TCT Asia Pacific meeting in Korea. Nobori 2 trial subgroup results on may 27, during the EuroPcr meeting. Biuosensors Q4 2010 results which will include the scorecard from the mkt in France. From the technical perspective, The stock has dropped closed to its 200 day mva, before rebounding yesterday. There is no sign of trend reversal yet (ie the stock is in an intermediate downtrend), until we see a base building effect ( ie a saucer shape formation, or a higher high being formed) but it is a good start. Looking at the weekly chart, a Japanese candlestick hammer has been formed, which often indicates that a bottom has been formed, and this signal will be more validated if the next candle ( ie the whole of next week) does not violate the 0.695 low. For info. Not a call to buy/sell. |
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
topdog22
Senior |
01-Apr-2010 01:42
|
||||
|
x 0
x 0 Alert Admin |
The BIG bet Let’s look at management’s stated objectives: Increase sales, Increase profitability, Unlock shareholder value. Based on these objectives management has achieved the first 2 goals: sustainable sales growth and sustainable profit growth generated by internally created sales. What appears to show little progress is creating shareholder value as reflected in a higher share price. Normally when sales and income increase, so does the share price, but not here, as yet. Especially in view of the latest share slump with no apparent trigger. BIG’s TOTAL VALUE case has been supported by Nomura based on the current sales and earning forecasts. The share price has NOT approached this value. These forecasts, although doubted by CS, seem reasonable based on the prior nine months actual data and the new product markets that have just been opened. We will all see shortly how accurate the forecasts have been, but my feeling is that Nomura is conservative and that there will be an upside surprise. (As is normally the situation, where management is trying to build value.) TERUMO will announce some clinical trial results shortly which, if similar to BIG’s trial results, will prove the efficacy of the BIG product and may also show it’s superiority to most larger rivals’ products. (As BIG demonstrated against J&J and thereby Boston, which is proven inferior to JNJ). This should have increase sales. Could it be that speculators have focused on M&A as a quick way to unlock value i.e. boost share price? BIG tried to capitalise it’s JWS partnership by purchasing the entire company but was forbidden by Chinese regulators. So how does BIG realize it’s investment? Could it, as suggested by Nomura, float JWS in China and then distribute the proceeds to shareholders? This scenario would see cash available for distribution of approximately .70 (if it realizes just the low end market estimate). As stated by Nomura, BIG’s technology may be attractive to other interventional players but Terumo should be the natural partner as it has an extensive license agreement in place. This license may be a draw back to other players as it grants access to Terumo of BIG’s proven existing technology. As there has been little progress on this front could speculators have become discouraged and fled? The BIG bet is: will good clinical results, increased sales and profitability be enough to move BIG’s share price closer to its value?? Your thoughts please |
||||
| Useful To Me Not Useful To Me | |||||
|
junction
Senior |
30-Mar-2010 19:22
|
||||
|
x 0
x 0 Alert Admin |
Is it based on your chart reading or some news? Wonder when the blood letting will stop.
|
||||
| Useful To Me Not Useful To Me | |||||
|
iPunter
Supreme |
30-Mar-2010 17:18
|
||||
|
x 0
x 0 Alert Admin |
.705/.71 is a good entry price ...
|
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
greendino
Member |
30-Mar-2010 17:08
|
||||
|
x 0
x 0 Alert Admin |
I would like to think that a reverse head and shoulder formation is forming..with the neckline at 80cts..I'm no chartist..ha...so i dunno where is the bottom...66cts? then again who's been selling?? can someone get some transparency in this selling? | ||||
| Useful To Me Not Useful To Me | |||||
|
pharoah88
Supreme |
30-Mar-2010 16:54
|
||||
|
x 0
x 0 Alert Admin |
where is the chart? it was an EightEr ?
|
||||
| Useful To Me Not Useful To Me | |||||
|
TuaPekGong9413
Elite |
30-Mar-2010 10:39
Yells: "deity" |
||||
|
x 3
x 0 Alert Admin |
those who vested at .705 earlier should be very happy now.....when stock turn down, ppl will speculate the reasons for its downtrend....reasons like obama bill health......bla bla bla.....more importantly is to see if the stock is overbought or oversold.... | ||||
| Useful To Me Not Useful To Me | |||||
|
iPunter
Supreme |
30-Mar-2010 09:00
|
||||
|
x 0
x 0 Alert Admin |
This is a good and interesting stock...  |
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
TuaPekGong9413
Elite |
30-Mar-2010 08:51
Yells: "deity" |
||||
|
x 0
x 0 Alert Admin |
deliberate pushdown for pushing up later... | ||||
| Useful To Me Not Useful To Me | |||||
|
kivine
Member |
30-Mar-2010 00:37
|
||||
|
x 0
x 0 Alert Admin |
at the rate this is going, support will be at 0.59 | ||||
| Useful To Me Not Useful To Me | |||||
|
greendino
Member |
29-Mar-2010 14:57
|
||||
|
x 0
x 0 Alert Admin |
serious selling man...sell Q is swelling up...maybe some insider news about medical trial issues? or simply a case of BB profit taking or shorting? it's alredy down 17% from its high. | ||||
| Useful To Me Not Useful To Me | |||||
|
allright
Senior |
29-Mar-2010 13:12
|
||||
|
x 0
x 0 Alert Admin |
This was reported on the 16th of march. What happrened after this for the share price to fall?
|
||||
| Useful To Me Not Useful To Me | |||||
|
Hulumas
Supreme |
25-Mar-2010 12:37
Yells: "INVEST but not TRADE please!" |
||||
|
x 0
x 0 Alert Admin |
Yes, it will move to that direction.
|
||||
| Useful To Me Not Useful To Me | |||||
|
Hulumas
Supreme |
25-Mar-2010 12:35
Yells: "INVEST but not TRADE please!" |
||||
|
x 0
x 0 Alert Admin |
Wise information.
|
||||
| Useful To Me Not Useful To Me | |||||
|
topdog22
Senior |
24-Mar-2010 23:36
|
||||
|
x 0
x 0 Alert Admin |
Well, I guess we know how predictive "chartview" is! I do not see how the US healthcare Bill could negatively impact BIG for: 1) BIG does NOT sell in the US: 2) It appears as though the bill will drive up consumption. The US has never effectively limited the amount medical drug or medical device companies have charged US people. If you look at the statistics, it is apparant the after Japan the US has the highest device and drug costs in the world. What do you think is causing this run? Senior seems to have a good insight |
||||
| Useful To Me Not Useful To Me | |||||
|
pharoah88
Supreme |
24-Mar-2010 18:21
|
||||
|
x 0
x 0 Alert Admin |
Health BiLL WiLL increase US Consumptions since peOple dO nOt have wOrry abOut Health Expenditure. There is nO nEEd tO savE fOr Health CARE anymOre in USA. DON'T CARE about HEALTHCARE as HEALTH BILL takes ALL CARE. SingapOreans savE and savE and savE because they are ALL wOrred abOut HEALTHCARE as there is nO HEALTH BILL tO take CARE or ALL HEALTH CARE
|
||||
| Useful To Me Not Useful To Me | |||||